![Shirish Dabir](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Historial de carrera de Shirish Dabir
Antiguos cargos conocidos de Shirish Dabir.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ELANTAS BECK INDIA LIMITED | Oficial de Cumplimiento | 03/04/2006 | 31/08/2018 |
Oficial de Recursos Humanos | 03/04/2006 | 31/08/2018 | |
Contacto de Relaciones con Inversores | 03/04/2006 | 31/08/2018 | |
Consejero General | 03/04/2006 | 31/08/2018 | |
Secretario Corporativo | 03/04/2006 | 31/08/2018 | |
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Secretario Corporativo | - | - |
Estadísticas
Internacional
India | 3 |
Operativa
Corporate Secretary | 2 |
Compliance Officer | 1 |
Human Resources Officer | 1 |
Sectorial
Process Industries | 2 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ELANTAS BECK INDIA LIMITED | Process Industries |
Empresas privadas | 1 |
---|---|
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Health Technology |
- Bolsa de valores
- Insiders
- Shirish Dabir
- Experiencia